Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Human haemoglobin - Northfield Laboratories

Drug Profile

Human haemoglobin - Northfield Laboratories

Alternative Names: PolyHeme

Latest Information Update: 14 May 2009

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Northfield Laboratories
  • Class Haemoglobins; Plasma expanders
  • Mechanism of Action Haemoglobin stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypovolaemia

Most Recent Events

  • 08 May 2009 Northfield Laboratories lays off substantially all of its operational and staff employees
  • 01 May 2009 Northfield Laboratories receives complete response letter from the FDA for PolyHeme in Hypovolaemia
  • 31 Dec 2008 PolyHeme receives priority review status for Hypovolaemia in the US
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top